Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387491879> ?p ?o ?g. }
- W4387491879 abstract "As a novel and promising antitumor target, AXL plays an important role in tumor growth, metastasis, immunosuppression and drug resistance of various malignancies, which has attracted extensive research interest in recent years. In this study, by employing the structure-based drug design and bioisosterism strategies, we designed and synthesized in total 54 novel AXL inhibitors featuring a fused-pyrazolone carboxamide scaffold, of which up to 20 compounds exhibited excellent AXL kinase and BaF3/TEL-AXL cell viability inhibitions. Notably, compound 59 showed a desirable AXL kinase inhibitory activity (IC50: 3.5 nmol/L) as well as good kinase selectivity, and it effectively blocked the cellular AXL signaling. In turn, compound 59 could potently inhibit BaF3/TEL-AXL cell viability (IC50: 1.5 nmol/L) and significantly suppress GAS6/AXL-mediated cancer cell invasion, migration and wound healing at the nanomolar level. More importantly, compound 59 oral administration showed good pharmacokinetic profile and in vivo antitumor efficiency, in which we observed significant AXL phosphorylation suppression, and its antitumor efficacy at 20 mg/kg (qd) was comparable to that of BGB324 at 50 mg/kg (bid), the most advanced AXL inhibitor. Taken together, this work provided a valuable lead compound as a potential AXL inhibitor for the further antitumor drug development." @default.
- W4387491879 created "2023-10-11" @default.
- W4387491879 creator A5006044740 @default.
- W4387491879 creator A5008549119 @default.
- W4387491879 creator A5017971231 @default.
- W4387491879 creator A5022860271 @default.
- W4387491879 creator A5030446424 @default.
- W4387491879 creator A5034036358 @default.
- W4387491879 creator A5044302048 @default.
- W4387491879 creator A5051763639 @default.
- W4387491879 creator A5057287134 @default.
- W4387491879 creator A5059378988 @default.
- W4387491879 creator A5061074781 @default.
- W4387491879 creator A5071803432 @default.
- W4387491879 creator A5075263856 @default.
- W4387491879 creator A5076042387 @default.
- W4387491879 creator A5079785852 @default.
- W4387491879 creator A5086559201 @default.
- W4387491879 creator A5090707730 @default.
- W4387491879 date "2023-10-01" @default.
- W4387491879 modified "2023-10-12" @default.
- W4387491879 title "Structure-based drug discovery of novel fused-pyrazolone carboxamide derivatives as potent and selective AXL inhibitors" @default.
- W4387491879 cites W1607701774 @default.
- W4387491879 cites W1964081206 @default.
- W4387491879 cites W1980673019 @default.
- W4387491879 cites W2046791164 @default.
- W4387491879 cites W2048008261 @default.
- W4387491879 cites W2059659850 @default.
- W4387491879 cites W2066404978 @default.
- W4387491879 cites W2083870593 @default.
- W4387491879 cites W2110462773 @default.
- W4387491879 cites W2117716725 @default.
- W4387491879 cites W2122375037 @default.
- W4387491879 cites W2149014007 @default.
- W4387491879 cites W2157711272 @default.
- W4387491879 cites W2235360349 @default.
- W4387491879 cites W2289087411 @default.
- W4387491879 cites W2346179770 @default.
- W4387491879 cites W2398437686 @default.
- W4387491879 cites W2417831449 @default.
- W4387491879 cites W2460888099 @default.
- W4387491879 cites W2541064047 @default.
- W4387491879 cites W2549442450 @default.
- W4387491879 cites W2568182039 @default.
- W4387491879 cites W2568917916 @default.
- W4387491879 cites W2605478093 @default.
- W4387491879 cites W2620546513 @default.
- W4387491879 cites W2727463864 @default.
- W4387491879 cites W2735085100 @default.
- W4387491879 cites W2758315173 @default.
- W4387491879 cites W2768772819 @default.
- W4387491879 cites W2784562745 @default.
- W4387491879 cites W2796558260 @default.
- W4387491879 cites W2808978641 @default.
- W4387491879 cites W2894996616 @default.
- W4387491879 cites W2901243719 @default.
- W4387491879 cites W2905025160 @default.
- W4387491879 cites W2911797927 @default.
- W4387491879 cites W2928325258 @default.
- W4387491879 cites W2948063335 @default.
- W4387491879 cites W2953384334 @default.
- W4387491879 cites W2955527549 @default.
- W4387491879 cites W2957307107 @default.
- W4387491879 cites W2985103021 @default.
- W4387491879 cites W2987630755 @default.
- W4387491879 cites W2999522193 @default.
- W4387491879 cites W3017329568 @default.
- W4387491879 cites W3036917216 @default.
- W4387491879 cites W3037433310 @default.
- W4387491879 cites W3041495079 @default.
- W4387491879 cites W3087478168 @default.
- W4387491879 cites W3090497711 @default.
- W4387491879 cites W3106863650 @default.
- W4387491879 cites W3137699554 @default.
- W4387491879 cites W3146597122 @default.
- W4387491879 cites W3151022772 @default.
- W4387491879 cites W3156489023 @default.
- W4387491879 cites W3171285656 @default.
- W4387491879 cites W3179520475 @default.
- W4387491879 cites W3194966427 @default.
- W4387491879 cites W3198358711 @default.
- W4387491879 cites W3210373905 @default.
- W4387491879 cites W4200019954 @default.
- W4387491879 cites W4211233744 @default.
- W4387491879 cites W4285742874 @default.
- W4387491879 cites W4308694108 @default.
- W4387491879 cites W4311635368 @default.
- W4387491879 doi "https://doi.org/10.1016/j.apsb.2023.10.002" @default.
- W4387491879 hasPublicationYear "2023" @default.
- W4387491879 type Work @default.
- W4387491879 citedByCount "0" @default.
- W4387491879 crossrefType "journal-article" @default.
- W4387491879 hasAuthorship W4387491879A5006044740 @default.
- W4387491879 hasAuthorship W4387491879A5008549119 @default.
- W4387491879 hasAuthorship W4387491879A5017971231 @default.
- W4387491879 hasAuthorship W4387491879A5022860271 @default.
- W4387491879 hasAuthorship W4387491879A5030446424 @default.
- W4387491879 hasAuthorship W4387491879A5034036358 @default.
- W4387491879 hasAuthorship W4387491879A5044302048 @default.
- W4387491879 hasAuthorship W4387491879A5051763639 @default.